advertisement
Xu F 31
Showing records 1 to 25 | Display all abstracts from Xu F109745 Inhibition of NOX4 with GLX351322 alleviates acute ocular hypertension-induced retinal inflammation and injury by suppressing ROS mediated redox-sensitive factors activation
Liao J
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2023; 165: 115052
110014 IGFBPL1 is a master driver of microglia homeostasis and resolution of neuroinflammation in glaucoma and brain tauopathy
Pan L
Cell reports 2023; 42: 112889
109706 A new gene-scoring method for uncovering novel glaucoma-related genes using non-negative matrix factorization based on RNA-seq data
Huang X
Frontiers in genetics 2023; 14: 1204909
110014 IGFBPL1 is a master driver of microglia homeostasis and resolution of neuroinflammation in glaucoma and brain tauopathy
Cho KS
Cell reports 2023; 42: 112889
109706 A new gene-scoring method for uncovering novel glaucoma-related genes using non-negative matrix factorization based on RNA-seq data
Bajpai AK
Frontiers in genetics 2023; 14: 1204909
109745 Inhibition of NOX4 with GLX351322 alleviates acute ocular hypertension-induced retinal inflammation and injury by suppressing ROS mediated redox-sensitive factors activation
Peng B; Huang G
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2023; 165: 115052
110014 IGFBPL1 is a master driver of microglia homeostasis and resolution of neuroinflammation in glaucoma and brain tauopathy
Wei X
Cell reports 2023; 42: 112889
109706 A new gene-scoring method for uncovering novel glaucoma-related genes using non-negative matrix factorization based on RNA-seq data
Sun J
Frontiers in genetics 2023; 14: 1204909
110014 IGFBPL1 is a master driver of microglia homeostasis and resolution of neuroinflammation in glaucoma and brain tauopathy
Xu F
Cell reports 2023; 42: 112889
109745 Inhibition of NOX4 with GLX351322 alleviates acute ocular hypertension-induced retinal inflammation and injury by suppressing ROS mediated redox-sensitive factors activation
Diao C
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2023; 165: 115052
109706 A new gene-scoring method for uncovering novel glaucoma-related genes using non-negative matrix factorization based on RNA-seq data
Xu F; Lu L
Frontiers in genetics 2023; 14: 1204909
109745 Inhibition of NOX4 with GLX351322 alleviates acute ocular hypertension-induced retinal inflammation and injury by suppressing ROS mediated redox-sensitive factors activation
Qin Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2023; 165: 115052
110014 IGFBPL1 is a master driver of microglia homeostasis and resolution of neuroinflammation in glaucoma and brain tauopathy
Lennikov A; Hu G
Cell reports 2023; 42: 112889
109706 A new gene-scoring method for uncovering novel glaucoma-related genes using non-negative matrix factorization based on RNA-seq data
Yousefi S
Frontiers in genetics 2023; 14: 1204909
109745 Inhibition of NOX4 with GLX351322 alleviates acute ocular hypertension-induced retinal inflammation and injury by suppressing ROS mediated redox-sensitive factors activation
Hong Y; Lin J
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2023; 165: 115052
110014 IGFBPL1 is a master driver of microglia homeostasis and resolution of neuroinflammation in glaucoma and brain tauopathy
Tang J; Guo S
Cell reports 2023; 42: 112889
109745 Inhibition of NOX4 with GLX351322 alleviates acute ocular hypertension-induced retinal inflammation and injury by suppressing ROS mediated redox-sensitive factors activation
Lin Y; Jiang L
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2023; 165: 115052
110014 IGFBPL1 is a master driver of microglia homeostasis and resolution of neuroinflammation in glaucoma and brain tauopathy
Chen J
Cell reports 2023; 42: 112889
109745 Inhibition of NOX4 with GLX351322 alleviates acute ocular hypertension-induced retinal inflammation and injury by suppressing ROS mediated redox-sensitive factors activation
Tang N
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2023; 165: 115052
110014 IGFBPL1 is a master driver of microglia homeostasis and resolution of neuroinflammation in glaucoma and brain tauopathy
Kriukov E; Kyle R
Cell reports 2023; 42: 112889
109745 Inhibition of NOX4 with GLX351322 alleviates acute ocular hypertension-induced retinal inflammation and injury by suppressing ROS mediated redox-sensitive factors activation
Tang F; Liang J
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2023; 165: 115052
110014 IGFBPL1 is a master driver of microglia homeostasis and resolution of neuroinflammation in glaucoma and brain tauopathy
Elzaridi F; Jiang S
Cell reports 2023; 42: 112889
109745 Inhibition of NOX4 with GLX351322 alleviates acute ocular hypertension-induced retinal inflammation and injury by suppressing ROS mediated redox-sensitive factors activation
Zhang J; Yan Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2023; 165: 115052
110014 IGFBPL1 is a master driver of microglia homeostasis and resolution of neuroinflammation in glaucoma and brain tauopathy
Dromel PA; Young M
Cell reports 2023; 42: 112889
109745 Inhibition of NOX4 with GLX351322 alleviates acute ocular hypertension-induced retinal inflammation and injury by suppressing ROS mediated redox-sensitive factors activation
Chen Q
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2023; 165: 115052